BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 10, 2020
View Archived Issues
C12orf49 is new lipid metabolism gene
Read More
Simultaneous dual base editing
Read More
Dual JAK1/TYK2 inhibitor TLL-018 shows dose-dependent anti-inflammatory activity in arthritis models
Read More
Phase I data presented for URAT1 inhibitor D-0120
Read More
FDA clears IND application for PTX-35
Read More
BeyondSpring presents positive data from PROTECTIVE-2 study of plinabulin plus Neulasta
Read More
First patient dosed in phase Ib study of RMC-4630 in combination with AMG-510
Read More
First-in-human data for MGD-013 in unresectable or metastatic neoplasms
Read More
HX-008 plus irinotecan show promising activity in advanced gastric adenocarcinoma
Read More
TV technology wants to be brain delivery's all-terrain vehicle
Read More
Loss-of-function mutations in JAM2 gene cause familial brain calcification
Read More
Phase I study finds manageable toxicity with LY-2880070 alone and with gemcitabine
Read More
Black Belt TX patents arginase inhibitors
Read More
Taisho Pharmaceutical discloses new antibacterials
Read More
Grey Wolf Therapeutics synthesizes ERAP1 inhibitors
Read More
Merck & Co. describes new adenosine A2A and/or A2B receptor antagonists
Read More
Opthea reports phase IIa topline data on OPT-302 for refractory DME
Read More
Bacainn announces phase I study initiation for ulcerative colitis candidate BT-051
Read More
NLRP3 inhibitors presented by Novartis Inflammasome Research
Read More
Wharton's jelly-derived mesenchymal stem cells effective in graft-versus-host disease trial
Read More
FDA allows phase III protocol for SPI-1005 for Meniere's disease
Read More
Fulcrum submits IND for phase III study of losmapimod for COVID-19
Read More
Pfizer reports topline data from JADE TEEN trial of abrocitinib in adolescent atopic dermatitis
Read More
NFlection initiates phase IIa study of NFX-179 gel for cutaneous NF-1
Read More